• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Chemours Company

    4/1/25 5:20:22 PM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email
    DEFA14A 1 tm2510986d1_defa14a.htm DEFA14A

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

      

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934 (Amendment No.   )

      

    Filed by the Registrant x ​ ​ Filed by a Party other than the Registrant ¨ ​

      

    Check the appropriate box:
    ¨ Preliminary Proxy Statement
    ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ¨ Definitive Proxy Statement
    x Definitive Additional Materials
    ¨ Soliciting Material under §240.14a-12

     

    THE CHEMOURS COMPANY

    (Name of Registrant as Specified in its Charter)

     

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):
    x No fee required.
    ¨ Fee paid previously with preliminary materials.
    ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11

      

     

     

      

      

    March 31, 2025

      

    Dear Fellow Shareholder:

      

    We have previously sent to you proxy materials for the Annual Meeting of Shareholders of The Chemours Company to be held on April 22, 2025. To date, we have not received your proxy. Your Board of Directors recommends that you vote FOR all of the nominees for director in Proposal 1, FOR Proposals 2, 3 and 4, and AGAINST Proposal 5.

      

    Since Proposal 4 requires approval by the affirmative vote of at least 80% of the outstanding shares, your vote is important, no matter how many or how few shares you may own. Proposal 4 seeks your approval to amend our Certificate of Incorporation such that, going forward, all amendments to our Certificate and Bylaws could be approved by only a majority of our outstanding shares, rather than the supermajority requirement (i.e., at least 80% of the outstanding shares) currently in place for certain matters. Your Board urges all shareholders to vote FOR Proposal 4.

      

    To ensure that your shares are represented at the Annual Meeting, please vote TODAY by telephone or via the Internet—electronic voting is quick and easy! If you received this letter by email, you may simply click on the “VOTE NOW” button in the accompanying email.

     

    Thank you for your support,

     

    Kristine M. Wellman

    Senior Vice President, General Counsel &

    Corporate Secretary

     

    REMEMBER: Failing to vote will count as a vote Against Proposal 4--please make sure your shares are represented!

     

    You may vote your shares by telephone or via the Internet.

    Please follow the easy instructions in the accompanying

    voting instruction form or email.

     

    If you have any questions or need assistance in voting

    your shares, please call our proxy solicitor:

      

    INNISFREE M&A INCORPORATED

    1 (877) 750-8315 (TOLL-FREE from the U.S. and Canada)

    or +1 (412) 232-3651 (From other countries)

     

     

      

     

    Get the next $CC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Dignam Denise bought $49,060 worth of shares (4,068 units at $12.06) (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    8/12/25 5:12:16 PM ET
    $CC
    Major Chemicals
    Industrials

    Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    6/4/25 8:32:18 PM ET
    $CC
    Major Chemicals
    Industrials

    Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    5/21/25 5:13:57 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chemours upgraded by Mizuho with a new price target

    Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00

    3/27/25 8:05:02 AM ET
    $CC
    Major Chemicals
    Industrials

    Truist initiated coverage on Chemours with a new price target

    Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00

    1/28/25 7:09:50 AM ET
    $CC
    Major Chemicals
    Industrials

    Chemours upgraded by UBS with a new price target

    UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously

    7/9/24 8:13:51 AM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    SEC Filings

    View All

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SEC Form 10-Q filed by Chemours Company

    10-Q - Chemours Co (0001627223) (Filer)

    11/6/25 4:34:47 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Chemours Co (0001627223) (Filer)

    11/6/25 4:32:10 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Chemours Co (0001627223) (Filer)

    10/31/25 4:32:48 PM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form 4 filed by Director Satterthwaite Livingston

    4 - Chemours Co (0001627223) (Issuer)

    10/2/25 10:42:02 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form 4 filed by Director Mather Courtney

    4 - Chemours Co (0001627223) (Issuer)

    10/2/25 10:38:19 AM ET
    $CC
    Major Chemicals
    Industrials

    Pres Advanced Performance Mat Familiar Calderon Gerardo covered exercise/tax liability with 1,294 shares, decreasing direct ownership by 4% to 33,950 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    9/3/25 7:52:40 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/Chemours appoints Michael Foley as President of Titanium Technologies Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects C

    12/4/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Fourth Quarter Dividend

    The Chemours Company ("Chemours") (NYSE:CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2025. The dividend will be paid on December 15, 2025, to stockholders of record as of the close of business on November 14, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Speciali

    10/29/25 5:00:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2025 financial results after market on Thursday, November 6, 2025. The Company expects to hold its conference call to discuss its third quarter 2025 financial results at 8:00 a.m. Eastern Time on Friday, November 7, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please visit inves

    10/16/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Chemours Company

    SC 13G/A - Chemours Co (0001627223) (Subject)

    11/12/24 9:55:16 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Chemours Company (Amendment)

    SC 13G/A - Chemours Co (0001627223) (Subject)

    2/9/24 8:50:19 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Chemours Company (Amendment)

    SC 13G/A - Chemours Co (0001627223) (Subject)

    1/24/24 9:46:44 AM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Leadership Updates

    Live Leadership Updates

    View All

    Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/Chemours appoints Michael Foley as President of Titanium Technologies Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects C

    12/4/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Appoints Matthew Conti as Chief Human Resources Officer

    Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

    6/12/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

    6/10/25 6:45:00 AM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Financials

    Live finance-specific insights

    View All

    Chemours Announces Fourth Quarter Dividend

    The Chemours Company ("Chemours") (NYSE:CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2025. The dividend will be paid on December 15, 2025, to stockholders of record as of the close of business on November 14, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Speciali

    10/29/25 5:00:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2025 financial results after market on Thursday, November 6, 2025. The Company expects to hold its conference call to discuss its third quarter 2025 financial results at 8:00 a.m. Eastern Time on Friday, November 7, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please visit inves

    10/16/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2025 financial results after market on Tuesday, August 5, 2025. The Company expects to hold its conference call to discuss its second quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, August 6, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please vi

    7/29/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials